This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Jul;149(1):142.

doi: 10.1016/j.jpeds.2006.04.030.

Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis

Affiliations

PMID: 17243308
DOI: 10.1016/j.jpeds.2006.04.030

Comment

Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis

Felix Ratjen. J Pediatr. 2006 Jul.

. 2006 Jul;149(1):142.

doi: 10.1016/j.jpeds.2006.04.030.

Author

Affiliation

¹ The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada.

PMID: 17243308
DOI: 10.1016/j.jpeds.2006.04.030

No abstract available

PubMed Disclaimer

Comment on

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. Elkins MR, et al. N Engl J Med. 2006 Jan 19;354(3):229-40. doi: 10.1056/NEJMoa043900. N Engl J Med. 2006. PMID: 16421364 Clinical Trial.

Similar articles

Inhaled hypertonic saline as a therapy for cystic fibrosis.
Elkins MR, Bye PT. Elkins MR, et al. Curr Opin Pulm Med. 2006 Nov;12(6):445-52. doi: 10.1097/01.mcp.0000245714.89632.b2. Curr Opin Pulm Med. 2006. PMID: 17053496 Review.
Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
Corcoran TE, Godovchik JE, Donn KH, Busick DR, Goralski J, Locke LW, Markovetz MR, Myerburg MM, Muthukrishnan A, Weber L, Lacy RT, Pilewski JM. Corcoran TE, et al. Pediatr Pulmonol. 2017 Sep;52(9):1142-1149. doi: 10.1002/ppul.23749. Epub 2017 Jul 24. Pediatr Pulmonol. 2017. PMID: 28737262 Free PMC article. Clinical Trial.
Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial.
Dentice RL, Elkins MR, Bye PT. Dentice RL, et al. J Physiother. 2012;58(1):33-40. doi: 10.1016/S1836-9553(12)70070-X. J Physiother. 2012. PMID: 22341380 Clinical Trial.
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
Nenna R, Midulla F, Lambiase C, De Castro G, Zicari AM, Indinnimeo L, Cimino G, Troiani P, Quattrucci S, Tancredi G. Nenna R, et al. Ital J Pediatr. 2017 Jul 15;43(1):60. doi: 10.1186/s13052-017-0376-6. Ital J Pediatr. 2017. PMID: 28709466 Free PMC article. Clinical Trial.
Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K, Bilton D. Hurt K, et al. Expert Rev Respir Med. 2012 Feb;6(1):19-26. doi: 10.1586/ers.11.87. Expert Rev Respir Med. 2012. PMID: 22283575 Review.

See all similar articles

Cited by

Nebulised hypertonic saline for cystic fibrosis.
Wark P, McDonald VM. Wark P, et al. Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Jun 14;6:CD001506. doi: 10.1002/14651858.CD001506.pub5. PMID: 30260472 Free PMC article. Updated.
Nebulised hypertonic saline for cystic fibrosis.
Wark P, McDonald VM, Smith S. Wark P, et al. Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD001506. doi: 10.1002/14651858.CD001506.pub5. Cochrane Database Syst Rev. 2023. PMID: 37319354 Free PMC article.
Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance.
Cresta F, Naselli A, Favilli F, Casciaro R. Cresta F, et al. BMJ Case Rep. 2013 Apr 29;2013:bcr2013009042. doi: 10.1136/bcr-2013-009042. BMJ Case Rep. 2013. PMID: 23632183 Free PMC article.
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
Dawson S, Girling CJ, Cowap L, Clark-Carter D. Dawson S, et al. Cochrane Database Syst Rev. 2023 Mar 29;3(3):CD013766. doi: 10.1002/14651858.CD013766.pub2. Cochrane Database Syst Rev. 2023. PMID: 36989170 Free PMC article. Review.
Timing of hypertonic saline inhalation for cystic fibrosis.
Elkins M, Dentice R. Elkins M, et al. Cochrane Database Syst Rev. 2020 Feb 28;2(2):CD008816. doi: 10.1002/14651858.CD008816.pub4. Cochrane Database Syst Rev. 2020. PMID: 32107770 Free PMC article.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.